MRI Apparent Diffusion Coefficient (ADC) as a Biomarker of Tumour Response: Imaging-Pathology Correlation in Patients with Hepatic Metastases from Colorectal Cancer (EORTC 1423)
暂无分享,去创建一个
A. Jackson | J. Theysohn | S. Litière | Yan Liu | J. Waterton | R. Pathak | N. deSouza | J. Ayuso | S. Stroobants | A. Chiti | C. Julié | Bart K. M. Jacobs | Maria Urbanowicz-Nijaki
[1] Jeppe Thagaard,et al. Development of a method for digital assessment of tumor regression grade in patients with rectal cancer following neoadjuvant therapy , 2022, Journal of pathology informatics.
[2] H. Schlemmer,et al. Quantification and reduction of cross-vendor variation in multicenter DWI MR imaging: results of the Cancer Core Europe imaging task force , 2022, European Radiology.
[3] J. Lätt,et al. Changes in apparent diffusion coefficient and pathological response in colorectal liver metastases after preoperative chemotherapy , 2022, Acta radiologica.
[4] N. Lundbom,et al. Treatment response of colorectal cancer liver metastases to neoadjuvant or conversion therapy: a prospective multicentre follow-up study using MRI, diffusion-weighted imaging and 1H-MR spectroscopy compared with histology (subgroup in the RAXO trial) , 2021, ESMO open.
[5] R. Lencioni,et al. Colorectal liver metastases: ADC as an imaging biomarker of tumor behavior and therapeutic response. , 2021, European journal of radiology.
[6] H. Lv,et al. Identifying response in colorectal liver metastases treated with bevacizumab: development of RECIST by combining contrast-enhanced and diffusion-weighted MRI , 2021, European Radiology.
[7] J. Brenton,et al. Biomarkers for site-specific response to neoadjuvant chemotherapy in epithelial ovarian cancer: relating MRI changes to tumour cell load and necrosis , 2021, British journal of cancer.
[8] N. Inan,et al. Intravoxel Incoherent Motion of Colon Cancer Liver Metastases for the Assessment of Response to Antiangiogenic Treatment: Results from a Pilot Study , 2020, Medical Principles and Practice.
[9] N. Thacker,et al. Considering tumour volume for motion corrected DWI of colorectal liver metastases increases sensitivity of ADC to detect treatment-induced changes , 2019, Scientific Reports.
[10] F. Schmeel. Variability in quantitative diffusion-weighted MR imaging (DWI) across different scanners and imaging sites: is there a potential consensus that can help reducing the limits of expected bias? , 2018, European Radiology.
[11] G. Beets,et al. Advanced imaging to predict response to chemotherapy in colorectal liver metastases - a systematic review. , 2017, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[12] N. Thacker,et al. A data-driven statistical model that estimates measurement uncertainty improves interpretation of ADC reproducibility: a multi-site study of liver metastases , 2017, Scientific Reports.
[13] A. Jackson,et al. Implementing diffusion-weighted MRI for body imaging in prospective multicentre trials: current considerations and future perspectives , 2017, European Radiology.
[14] D. Caramella,et al. 3T diffusion-weighted MRI in the response assessment of colorectal liver metastases after chemotherapy: Correlation between ADC value and histological tumour regression grading. , 2017, European journal of radiology.
[15] D. Collins,et al. Extracranial Soft-Tissue Tumors: Repeatability of Apparent Diffusion Coefficient Estimates from Diffusion-weighted MR Imaging. , 2017, Radiology.
[16] Stuart A. Taylor,et al. Imaging biomarker roadmap for cancer studies , 2016, Nature Reviews Clinical Oncology.
[17] J. Han,et al. Diffusion-Related MRI Parameters for Assessing Early Treatment Response of Liver Metastases to Cytotoxic Therapy in Colorectal Cancer. , 2016, AJR. American journal of roentgenology.
[18] D. Collins,et al. Development of a temperature-controlled phantom for magnetic resonance quality assurance of diffusion, dynamic, and relaxometry measurements. , 2016, Medical physics.
[19] Andrew N Priest,et al. A framework for optimization of diffusion-weighted MRI protocols for large field-of-view abdominal-pelvic imaging in multicenter studies. , 2015, Medical physics.
[20] Matthew A Kupinski,et al. Diffusion MRI with Semi-Automated Segmentation Can Serve as a Restricted Predictive Biomarker of the Therapeutic Response of Liver Metastasis. , 2015, Magnetic resonance imaging.
[21] Stefan Klein,et al. The Accuracy of ADC Measurements in Liver Is Improved by a Tailored and Computationally Efficient Local-Rigid Registration Algorithm , 2015, PloS one.
[22] N M deSouza,et al. Diffusion-weighted MRI for imaging cell death after cytotoxic or apoptosis-inducing therapy , 2015, British Journal of Cancer.
[23] D. Collins,et al. Modelling DW-MRI data from primary and metastatic ovarian tumours , 2015, European Radiology.
[24] A. Padhani,et al. Apparent diffusion coefficient measurements as very early predictive markers of response to chemotherapy in hepatic metastasis: A preliminary investigation of reproducibility and diagnostic value , 2014, Journal of magnetic resonance imaging : JMRI.
[25] B. Seifert,et al. Diffusion-weighted MR imaging of upper abdominal organs: field strength and intervendor variability of apparent diffusion coefficients. , 2014, Radiology.
[26] Timothy D Johnson,et al. Multi‐system repeatability and reproducibility of apparent diffusion coefficient measurement using an ice‐water phantom , 2013, Journal of magnetic resonance imaging : JMRI.
[27] J. Bussink,et al. Diffusion-weighted MR imaging in liver metastases of colorectal cancer: reproducibility and biological validation , 2013, European Radiology.
[28] R. Boubertakh,et al. In vitro and in vivo repeatability of abdominal diffusion-weighted MRI. , 2012, The British journal of radiology.
[29] D. Driman,et al. Infarct-like Necrosis: A Distinct Form of Necrosis Seen in Colorectal Carcinoma Liver Metastases Treated With Perioperative Chemotherapy , 2012, The American journal of surgical pathology.
[30] N. Thacker,et al. Quantifying heterogeneity in human tumours using MRI and PET. , 2012, European journal of cancer.
[31] R. Meuli,et al. Interobserver and intraobserver variability of the apparent diffusion coefficient in treated malignant hepatic lesions on a 3.0T machine: Measurements in the whole lesion versus in the area with the most restricted diffusion , 2010, Journal of magnetic resonance imaging : JMRI.
[32] G. Beets,et al. Value of ADC measurements for nodal staging after chemoradiation in locally advanced rectal cancer—a per lesion validation study , 2010, European Radiology.
[33] Giacomo Belli,et al. MR‐diffusion weighted imaging of healthy liver parenchyma: Repeatability and reproducibility of apparent diffusion coefficient measurement , 2010, Journal of magnetic resonance imaging : JMRI.
[34] E. Merkle,et al. Field Strength and Diffusion Encoding Technique Affect the Apparent Diffusion Coefficient Measurements in Diffusion-Weighted Imaging of the Abdomen , 2010, Investigative radiology.
[35] P. Choyke,et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. , 2009, Neoplasia.
[36] S. Nawano,et al. The effect of simultaneous use of respiratory triggering in diffusion-weighted imaging of the liver. , 2006, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.
[37] L. Rubbia‐Brandt,et al. Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.